α-Glucosidase |
| Catalog No.GC63270 |
α-글루코시다제(α-D-글루코시다제)는 탄수화물 분해 효소로, 기질의 비환원 끝에서 α-글루코스를 해방하는 반응을 촉매합니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 9001-42-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
α-Glucosidase is a carbohydrate hydrolase that catalyzes the release of alpha-glucosidase from the non-reducing end of the substrate. Inhibition of α-Glucosidase is an effective method for non-insulin-dependent diabetes mellitus (NIDDM) [1-2]. Partial or complete deficiency of alpha-glucosidase can cause Pompe disease[3-4].
References:
[1]. Kumar S, Narwal S,et,al. α-glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacogn Rev. 2011 Jan;5(9):19-29. doi: 10.4103/0973-7847.79096. PMID: 22096315; PMCID: PMC3210010.
[2]. van de Laar FA, Lucassen PL, ,et,al. Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care. 2005 Jan;28(1):154-63. doi: 10.2337/diacare.28.1.154. PMID: 15616251.
[3]. Kohler L, Puertollano R, ,et,al. Pompe Disease: From Basic Science to Therapy. Neurotherapeutics. 2018 Oct;15(4):928-942. doi: 10.1007/s13311-018-0655-y. PMID: 30117059; PMCID: PMC6277280.
[4]. Morales A, Anilkumar AC. Glycogen Storage Disease Type II. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470558/
Average Rating: 5 (Based on Reviews and 13 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *